Sign In
to Vote &
Create Storyboards.
 
Intravenous/Sublingual Tissue-Penetrating Homing Peptide Enhances Activity of Other Pulmonary Drugs, According to New Research Published in The American Journal of Pathology.The development of new, more effective vasodilators to treat pulmonary arterial hypertension (PAH) has been hampered because of their systemic toxicity and adverse side effects.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard